Cannabidiol, currently prescribed to epilepsy patients, should be looked at as a possible preventative or treatment for COVID-19, a new study recommends.

Join The Ecosystem

Leave a Reply

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}